417 related articles for article (PubMed ID: 28402145)
1. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
Hamed R; AlJanabi R; Sunoqrot S; Abbas A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
[TBL] [Abstract][Full Text] [Related]
2. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
[TBL] [Abstract][Full Text] [Related]
3. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
[TBL] [Abstract][Full Text] [Related]
4. Physiological parameters of the gastrointestinal fluid impact the dissolution behavior of the BCS class IIa drug valsartan.
Hamed R
Pharm Dev Technol; 2018 Dec; 23(10):1168-1176. PubMed ID: 30320540
[TBL] [Abstract][Full Text] [Related]
5. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
6. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
7. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
8. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
10. pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.
Hamed R; Awadallah A; Sunoqrot S; Tarawneh O; Nazzal S; AlBaraghthi T; Al Sayyad J; Abbas A
AAPS PharmSciTech; 2016 Apr; 17(2):418-26. PubMed ID: 26202065
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Within-Tablet Dynamics for Extended Release of a Poorly Soluble Basic Drug from Hydrophilic Matrix Tablets Using ATR-FTIR Imaging.
Zahoor FD; Mader KT; Timmins P; Brown J; Sammon C
Mol Pharm; 2020 Apr; 17(4):1090-1099. PubMed ID: 32069060
[TBL] [Abstract][Full Text] [Related]
12. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
13. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
Ali R; Dashevsky A; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
[TBL] [Abstract][Full Text] [Related]
14. An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance - case study of multimodal characterization of quetiapine fumarate tablets.
Kulinowski P; Woyna-Orlewicz K; Rappen GM; Haznar-Garbacz D; Węglarz WP; Dorożyński PP
Int J Pharm; 2015 Apr; 484(1-2):235-45. PubMed ID: 25701626
[TBL] [Abstract][Full Text] [Related]
15. Original research paper. Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach.
Gavan A; Porfire A; Marina C; Tomuta I
Acta Pharm; 2017 Mar; 67(1):53-70. PubMed ID: 28231048
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
Hamed R; Al Baraghthi T; Sunoqrot S
Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
[TBL] [Abstract][Full Text] [Related]
17. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
Khanvilkar KH; Huang Y; Moore AD
Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status.
Guiastrennec B; Söderlind E; Richardson S; Peric A; Bergstrand M
Pharm Res; 2017 Apr; 34(4):847-859. PubMed ID: 28155077
[TBL] [Abstract][Full Text] [Related]
19. The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine.
Nie S; Pan W; Li X; Wu X
Drug Dev Ind Pharm; 2004 Jul; 30(6):627-35. PubMed ID: 15285336
[TBL] [Abstract][Full Text] [Related]
20. Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.
Klančar U; Baumgartner S; Legen I; Smrdel P; Kampuš NJ; Krajcar D; Markun B; Kočevar K
AAPS PharmSciTech; 2015 Apr; 16(2):398-406. PubMed ID: 25331194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
